Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?

Affiliations

¹ VCU Pauley Heart Center, Virginia Commonwealth University, 1200 E. Broad street, Box 980281, Richmond, VA, 23298, USA aabbate@vcu.edu.
² Department of Medicine, University of Colorado, Aurora, CO, USA.

Editorial

Antonio Abbate et al. Eur Heart J. 2015.

. 2015 Feb 7;36(6):337-9.

doi: 10.1093/eurheartj/ehu369. Epub 2014 Sep 8.

¹ VCU Pauley Heart Center, Virginia Commonwealth University, 1200 E. Broad street, Box 980281, Richmond, VA, 23298, USA aabbate@vcu.edu.
² Department of Medicine, University of Colorado, Aurora, CO, USA.

No abstract available

Comment on

The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study.
Morton AC, Rothman AM, Greenwood JP, Gunn J, Chase A, Clarke B, Hall AS, Fox K, Foley C, Banya W, Wang D, Flather MD, Crossman DC. Morton AC, et al. Eur Heart J. 2015 Feb 7;36(6):377-84. doi: 10.1093/eurheartj/ehu272. Epub 2014 Jul 30. Eur Heart J. 2015. PMID: 25079365 Free PMC article. Clinical Trial.